Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Features

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Michael O'Riordan

October 17, 2025

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

News Conference News HRS 2024

Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus

Michael O'Riordan

May 23, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Conference News ACC 2023

Studies Support (Careful) Return to Sport for Athletes With Genetic Conditions

Michael O'Riordan

March 07, 2023

News Features

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Shelley Wood

December 20, 2022

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Daily News

AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis

Yael L. Maxwell

February 24, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Features

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

Todd Neale

November 02, 2020

News Daily News

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Michael O'Riordan

August 09, 2018

News Daily News

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Michael O'Riordan

February 20, 2018

News Daily News

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

Yael L. Maxwell

August 23, 2016

Advertisement

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Studies Support (Careful) Return to Sport for Athletes With Genetic Conditions

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content